Alertness: nootropics and compounds | sci-wiki

Caffeine

Caffeine is a central nervous system stimulant of the methylxanthine class and the most widely consumed psychoactive substance in the world. A purine alkaloid found naturally in coffee beans, tea leaves, cacao, and other plants, it is used to restore alertness, reduce fatigue, and sharpen concentration. It is legal and largely unregulated in most countries, and it also has established medical uses, including the treatment of apnea in premature infants.

2 outlets

Nootropic

Modafiendz

Modafiendz is a fluorinated, N-methylated analog of the wakefulness agent modafinil, marketed online as a next-generation nootropic alternative. It is built around the same eugeroic blueprint that made modafinil a favorite for focus and sustained alertness, with structural tweaks intended to modify its activity. Because the analog itself has not been formally studied, it is best understood as an experimental research chemical riding on the well-mapped pharmacology of its parent.

1 outlet

Nootropic

Taltirelin

Taltirelin (TA-0910, brand name Ceredist) is a synthetic, metabolically stable analog of thyrotropin-releasing hormone (TRH), the three-residue hypothalamic peptide. It was developed by Tanabe Seiyaku and approved in Japan in 2000 for spinocerebellar degeneration, where it is taken orally to help with ataxia and related symptoms. The interesting thing about taltirelin is that it was engineered to keep the central nervous system effects of TRH while shedding most of the hormonal ones; it is roughly 10 to 100 times more potent than native TRH at driving CNS arousal, yet its effect on thyroid hormone release is much weaker. It also lasts far longer in the body because it resists the enzymes that chew up natural TRH within minutes. Outside its approved use it gets discussed in nootropic and biohacker circles as a wakefulness-promoting, pro-cholinergic "analeptic" and neuroprotective agent, and there is a real preclinical literature behind those claims (Parkinson's models, ischemia, pain, respiratory stimulation). Human data outside spinocerebellar degeneration is thin, so most of what you read about it as a cognitive enhancer is extrapolation from animal work.

1 outlet

Nootropic

Phenylpiracetam Hydrazide

Phenylpiracetam Hydrazide (fonturacetam hydrazide) is a structural variant of phenylpiracetam in which the racetam's amide group is replaced by a hydrazide, marketed as a next-generation twist on one of the most potent racetam nootropics [4]. Its appeal rests on the phenylpiracetam framework, a scaffold known for selective dopamine transporter inhibition and stimulant-like focus, endurance, and cold resistance [2][5]. It is sold strictly as a research chemical, and its own pharmacology has not been characterized in published human or animal studies, so its profile is inferred from the phenylpiracetam parent it is built upon [3][4].

2 outlets

Nootropic

Arecoline

Arecoline is the main alkaloid of the areca nut and a partial agonist at both muscarinic and nicotinic acetylcholine receptors; it is the pharmacologically active core of betel quid chewing rather than a therapeutic agent.

reference

Nootropic

Besipirdine

Besipirdine was Hoechst-Roussel's attempt to broaden the cholinergic-hypothesis playbook for Alzheimer's disease by hitting two neurotransmitter systems at once, enhancing both cholinergic and noradrenergic transmission rather than acetylcholine alone, on the theory that a dual mechanism might outperform pure cholinesterase inhibitors. In a 275-patient trial, patients on besipirdine held steady on cognitive testing over three months while the placebo group declined, a genuinely encouraging signal for a still-experimental Alzheimer's drug in the mid-1990s. That promise collapsed in Phase III, where a subset of patients developed serious cardiovascular side effects, forcing Hoechst-Roussel to abandon the program; the company had also explored besipirdine for other indications, including multiple sclerosis-related walking impairment, but none of it reached market.

reference

Nootropic

CX-717

CX-717 is a later, more brain-penetrant ampakine (Cortex Pharmaceuticals, later RespireRx) notable for offsetting sleep-deprivation cognitive decline in nonhuman primates and, at high dose, in humans, plus a distinct adult-ADHD development track. It has a 'low-impact' AMPA-PAM profile.

reference

Nootropic

Suritozole

Suritozole took the opposite approach from a sleeping pill; instead of boosting GABA-A signaling like a benzodiazepine, Marion Merrell Dow (via the MDL research code) built it as a partial inverse agonist at the benzodiazepine site, a molecule meant to dial GABA-A activity down just enough to sharpen memory and arousal without tipping into the anxiety or seizures that full inverse agonists cause. It moved into clinical evaluation for both depression and Alzheimer's-related memory loss in the 1990s, backed by animal data showing it could blunt cognitive impairment after traumatic brain injury in rats. The clinical program quietly stopped without ever producing published efficacy results, leaving it as a research reagent rather than a medicine.

reference

Nootropic

Theophylline

Theophylline is a naturally occurring methylxanthine (1,3-dimethylxanthine) that has been used as a bronchodilator and respiratory stimulant for more than 80 years. Structurally related to caffeine and theobromine and found in trace amounts in tea and cocoa, it relaxes airway smooth muscle and stimulates respiration through a combination of non-selective phosphodiesterase inhibition and adenosine receptor antagonism. At the low plasma concentrations achieved with modern sustained-release dosing, it also exerts anti-inflammatory effects by restoring histone deacetylase-2 (HDAC2) activity, a mechanism that can reverse corticosteroid resistance in severe asthma and chronic obstructive pulmonary disease (COPD). Because it has a narrow therapeutic window and numerous drug interactions, it is now generally reserved as an add-on therapy after inhaled agents.

reference